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Abstract
Mice carrying the recessive peripheral T cell deficiency (Ptcd) locus have a block in thymic egress 
but the mechanism responsible is undefined. Here we found that Ptcd T cells have an intrinsic 
migration defect, impaired lymphoid tissue trafficking and irregularly shaped protrusions. 
Characterization of the Ptcd locus revealed an E26K point mutation within the actin regulator 
coronin-1A (Coro1a) that enhanced its inhibition of the actin regulator Arp2/3 and resulted in its 
mislocalization from the leading edge of migrating T cells. Discovery of another Coro1a mutant 
during an N-ethyl-N-nitrosourea (ENU) mutagenesis screen for T cell lymphopenic mice prompted 
us to evaluate a T cell-deficient, B cell- and NK cell-sufficient (T−B+NK+) severe combined 
immunodeficiency (SCID) patient, whom we found had mutations in both CORO1A alleles. These 
findings establish a role for coronin-1A in T cell egress, identify a surface of coronin involved in 
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Arp2/3 regulation, and reveal actin regulation as a biological process defective in human and 
mouse SCID.
INTRODUCTION
Following development in the thymus, mature thymocytes upregulate sphingosine-1-
phosphate receptor 1 (S1P1) and exit into the circulation to populate the naive T cell 
compartment. S1P1 and its ligand sphingosine-1-phosphate (S1P) are required for egress of 
mature thymocytes 1. FTY720, a small molecule immunosuppressant in clinical trials for 
treatment of autoimmune disease, inhibits egress by modulating S1P1 function 1. Beyond 
the S1P1 requirement, little is understood about how T cells migrate out of the thymus.
The Cataract Shionogi (CTS) strain was initially isolated in the 1960’s from a closed colony 
of ICR mice for exhibiting cataracts and microphthalmia 2. The CTS strain was later 
established to have a thymic egress defect 3 after it failed to reject MHC-disparate skin 
grafts 4. The nature of this recessive defect, named peripheral T cell deficiency (Ptcd), and 
its role in thymic egress has been unclear.
Coronins are actin regulators found in all eukaryotes 5. In addition to binding F-actin, 
coronins associate with and inhibit the nucleation-promoting Arp2/3 complex. Seven 
coronin family members exist in mammals, including coronin-1A (Coro1A), which is 
predominantly expressed in hematopoeitic cells. Coro1A-deficient mice have reduced 
peripheral T cells due to increased apoptosis 6,7 and in one study this was attributed to an 
excessive accumulation of F-actin 6. T cell migration was also reported to be defective 6,7, 
but this has been called into question 8. The latter authors also question whether Coro1A 
deficiency alters F-actin dynamics, and instead link the increased apoptosis to a T cell 
receptor (TCR) signaling defect 8. These conflicting reports with Coro1a-null mice have 
complicated the understanding of this actin regulator’s role in T cell biology.
Here, we report that Ptcd T cells have an intrinsic migration defect that impairs thymic 
egress and trafficking through lymph nodes. We narrowed the Ptcd locus and identified a 
point mutation within Coro1A that causes mislocalization of the protein in T cells and 
increases its inhibition of Arp2/3 in biochemical assays. In a parallel effort to identify 
further trafficking mutants by screening mice carrying ENU-induced mutations for altered 
peripheral T cell numbers, we identified a strain that has 10-fold reduced Coro1A abundance 
and shows a similar phenotype to Coro1a ‘knockout’ mice. Comparison of Ptcd and 
Coro1A-deficient T cells allowed us to separate the defect in TCR-induced Ca++ signaling 
from the reduction in thymocyte surival. In addition to yielding new alleles of Coro1a, our 
mouse forward genetic approach led us to identify a T−B+NK+ SCID patient with CORO1A 
deficiency.
RESULTS
Ptcd is an intrinsic T cell migration defect
To characterize the cellular basis for the Ptcd defect, we first backcrossed the Ptcd locus 
onto the C57BL/6 (B6) strain and confirmed the accumulation of mature single-positive 
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(SP) thymocytes (CD69lo CD62Lhi) and associated decrease in peripheral T cells (Fig. 1a 
and Supplementary Fig. 1 online). Irradiated wild-type mice that had been reconstituted with 
Ptcd bone marrow cells also had an accumulation of mature thymocytes and low circulating 
T cells (Fig. 1b) whereas reciprocal bone marrow chimeras did not exhibit such defects 
(Supplementary Fig. 2 online). These results localized the Ptcd defect to a hematopoeitic-
derived cell and implicated impaired thymic egress of mature thymocytes as a pathogenic 
mechanism.
While normal amounts of S1P1 were expressed on Ptcd mature SP thymocytes (Fig. 1c), 
S1P1 function was impaired. In transwell migration assays, Ptcd mature CD4SP thymocytes 
were less efficient at migrating towards S1P than cells from control heterozygous littermates 
(Fig. 1d). The cells also migrated less efficiently to chemokines CCL21 and CXCL12. The 
response of Ptcd CD4 and CD8 double-positive (DP) thymocytes to CXCL12 was similarly 
reduced (Fig. 1e) and migration of Ptcd naïve splenic T cells was impaired while B cells 
migrated normally (Fig. 1f). Expression of CCR7 and CXCR4, the respective chemokine 
receptors that recognize CCL21 and CXCL12, were similar between Ptcd and control cells 
(Supplementary Fig. 3 online). These results indicate that T cells in Ptcd mice have a 
general, cell-intrinsic migration defect that impairs S1P1 responsiveness and blocks thymic 
egress.
Ptcd T cells have entry, egress and motility defects
To test for peripheral trafficking defects, Ptcd and control T cells were co-transferred into 
wildtype recipients. At 1 h post-transfer, the ratio of Ptcd:control T cells was decreased in 
peripheral and mesenteric lymph nodes and increased in blood (Fig. 2a) indicating that Ptcd 
cells are less efficient at entering lymph nodes. Next, lymph node egress was tested using 
two approaches. First, Ptcd and control T cells were co-transferred at a 3:1 ratio to achieve 
equal proportions in the lymph nodes. At 24 h after transfer a significantly reduced 
proportion of Ptcd cells were found in lymph compared to lymph nodes (Fig. 2b) consistent 
with a reduced ability to exit into lymph. As an additional approach, we assessed the 
retention of Ptcd T cells within lymph nodes. After transfer of Ptcd and control T cells, 
entry into lymph nodes was blocked for 20 h with integrin-neutralizing antibodies. Roughly 
60% of Ptcd T cells were retained in the lymph nodes compared with just 20% of control T 
cells (Fig. 2c). Together, these results demonstrate that Ptcd T cells are defective in exiting 
lymph nodes.
Two-photon microscopy on explanted lymph nodes from mice that had received 
fluorescently labeled cells showed that while control cells moved at median velocities of 9.5 
microns/min, Ptcd cells moved at reduced median velocities of 6.6 microns/min (Fig. 2d and 
Supplementary Movie 1 online). In addition, Ptcd cells had increased turning angles (Fig. 
2e), indicative of less directed paths and the cells failed to efficiently displace over time 
(Fig. 2f). These results demonstrate that in addition to blocking thymic egress, the Ptcd 
defect impairs trafficking through lymph nodes.
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Coronin-1A is mutated at the Ptcd locus
The Ptcd locus was previously mapped to a 10.9 Mb region of chromosome 7 containing 
over 300 open reading frames 9. To refine the locus, we performed a mapping cross between 
CTS and B6, using the thymocyte accumulation to phenotype mice (Fig. 3a). We observed 
that the cataracts and microphthalmia were in F1 hybrids and failed to co-segregate with the 
recessive Ptcd trait (data not shown), consistent with an early report that these eye traits 
were autosomal dominant 10. After analyzing over 900 meiosis events, we further mapped 
the Ptcd locus to a 950 kb critical interval (Fig. 3b). This gene-rich interval contained 37 
open reading frames including Coro1a (Fig. 3c). Coro1a was an attractive candidate gene 
for Ptcd because of its abundance in T cells 11 and the association of coronin family 
molecules with actin-based motility 5. Sequencing of Ptcd DNA revealed a G->A mutation 
in exon 2 of Coro1a (Fig. 3d), resulting in a non-conservative Glu->Lys substitution at 
residue 26 (E26K) in the beta-propeller domain (Fig. 3e). This residue is conserved in all 
annotated Coro1A sequences as well as charge conserved in a broad number of orthologs 
(Supplementary Fig. 4, online) and is in a surface exposed loop 12 adjacent to a region 
implicated in the close relative, Coro1B, as an actin binding site 13. Immunoblot analysis 
showed Coro1A abundance in total thymocytes did not vary between Ptcd and controls (Fig. 
3f).
To exclude that mutations other than Coro1AE26K may be responsible for the Ptcd 
phenotype, we tested for genetic complementation by crossing Ptcd with Coro1a+/− mice. 
As expected, the Coro1a wild-type allele complemented Ptcd defects in T cell lymphopenia 
and F-actin accumulation while the Coro1a null allele failed to complement (Supplementary 
Fig. 5a,b, online). In addition, mature thymocyte numbers in Ptcd/− mice were slightly 
elevated compared to Ptcd/+ (Supplementary Fig. 5c, online). While these studies do not 
exclude the possibility that the Ptcd interval contains additional genetic modifiers, the 
inability of the Coro1a null allele to rescue several of the Ptcd defects provides strong 
evidence that the Coro1AE26K mutation results in the Ptcd phenotype.
ENU-mutant Koyaanisqatsi is a Coronin-1A hypomorph
In parallel to the above studies, we conducted an ENU mutagenesis screen to identify 
regulators of lymphocyte trafficking and egress. Koyaanisqatsi (Koy) was initially identified 
as a recessive mutant with a circulating T cell deficiency (Fig. 4a). Further characterization 
of Koy mice revealed a decrease both in mature thymocyte numbers and peripheral T cells 
(Fig. 4b and Supplementary Fig. 6). In transwell migration assays, Koy thymocytes and 
naive T cells migrated much less efficiently than littermate control cells (Fig. 4c). These 
findings in the Koy mice, along with an elevated phalloidin staining in Koy mature 
thymocytes (Fig. 4d), resembled those reported in Coro1a−/− mice generated by gene 
targeting 6. Upon sequencing Koy DNA, we identified an A->T substitution in exon 7 of 
Coro1a (Fig. 4e) resulting in an Asp->Val mutation at residue 278. This residue is located at 
a contact surface predicted to be critical for the proper assembly and stability of Coro1A 12, 
and immunoblot analysis of total thymocytes showed that Koy cells had roughly 10-fold 
reduced amounts of Coro1A (Fig. 4f). Taken together, these data indicate that Koy is a 
hypomorphic mutant of Coro1A.
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Survival and Ca2+ flux in Coronin-1A mutants
A direct comparison of Ptcd with Koy and Coro1a−/− mice confirmed that the E26K 
mutation does not phenocopy the Coro1A deficient state. While Ptcd mutants have an 
accumulation of mature thymocytes (Fig. 1a), Coro1A-deficient mice have reduced numbers 
(Fig. 4b) due to reduced cell survival 6. Analysis of cell viability by loss of mitochondrial 
membrane potential (Fig. 5a) and annexin-V staining (Fig. 5b) revealed that mature 
thymocytes from Ptcd mice were comparable to wild-type controls whereas mature 
thymocytes from Coro1a−/− mice had reduced viability. However, Ptcd splenic T cells 
showed a similar defect in survival to Coro1a−/− cells (Fig. 5a,b).
A previous study has attributed the survival defect of Coro1a−/− T cells to downstream 
effects of excessive F-actin accumulation 6. Consistent with this interpretation, Ptcd mature 
thymocytes showed only a minor increase in F-actin as measured by phalloidin staining 
(Fig. 5c) whereas Coro1a−/− mature thymocytes and the similarly apoptosis prone Ptcd and 
Coro1a−/− splenic T cells all showed comparable two-fold elevations in phalloidin staining 
(Fig. 5c). However, the correlation between F-actin accumulation and reduced viability did 
not seem to hold for Ptcd/− T cells as they showed a similar elevation in phalloidin staining 
to Coro1a−/− T cells and yet were not reduced in number within the thymus (Supplementary 
Fig. 5). A recent study has suggested that the reduced viability of Coro1a−/− cells reflects a 
requirement for Coro1A in TCR-induced Ca2+ flux rather than in F-actin regulation 8. 
However, Ptcd and Coro1A-deficient mature CD4 SP thymocytes showed comparable Ca2+ 
flux defects following CD3 crosslinking (Fig. 5d). Furthermore, both Ptcd and Coro1A-
deficient cells showed minimal defects in comparison to wild-type following co-crosslinking 
of CD3 and CD4, a treatment that may more closely mimic major histocompatibility 
complex class II-peptide engagement 14 (Fig. 5d). These findings dissociate the role of 
Coro1A in TCR-induced Ca2+ signaling from its role in thymocyte viability, but leave it 
unclear whether Coro1A acts via F-actin regulation or by some other mechanism to promote 
T cell survival.
Coro1AE26K is mislocalized in Ptcd T cells
Coro1B regulates F-actin dynamics at the leading edge of migrating fibroblasts 15 and in 
migrating wild-type T cells, Coro1A was situated in F-actin– and Arp2/3-rich leading edge 
protrusions (Fig. 6a,b). The distribution of Coro1AE26K in migrating Ptcd T cells was 
markedly altered and little of the protein could be detected at the leading edge (Fig. 6a), 
while Arp2/3 continued to concentrate in this region (Fig. 6b). Coro1AE26K also similarly 
mislocalized when expressed in fibroblasts (Supplementary Fig. 7 online), indicating an 
intrinsic failure to distribute at the leading edge.
Real-time live cell imaging revealed that protrusions from migrating Ptcd T cells were 
irregularly shaped and often larger in size than protrusions in wild-type cells, consistent with 
a failure to properly regulate the actin cytoskeleton (Fig. 6c and Supplementary Movies 2–4 
online). Similarly dysmorphic protrusions were observed with Ptcd/− compound mutant T 
cells (Supplementary Fig. 5d). The short in vitro survival of Coro1A-deficient T cells made 
assessments difficult, but these cells appeared more severely compromised in their migration 
than Ptcd T cells (Supplementary Movie 5 online). Together, these results establish that 
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Coro1AE26K fails to distribute correctly in migrating T cells and the cells exhibit aberrant 
shape regulation.
E26K mutation in Coronin-1A enhances Arp2/3 inhibition
To understand the biochemical impact of the E26K mutation, we first looked at Coro1A’s 
ability to bind F-actin. In co-sedimentation assays, Coro1AE26K associated normally with F-
actin (Fig. 6d). By contrast, Arp2/3 co-immunoprecipitated increased amounts of 
Coro1AE26K from cell lysates relative to the wild-type protein (Fig. 6e). The corresponding 
mutation in Coro1B also resulted in an increased association with Arp2/3 (Supplementary 
Fig. 8 online). Consistent with increased interaction with Arp2/3, Coro1AE26K was more 
efficient than wild-type Coro1A at inhibiting Arp2/3 activity in actin polymerization assays 
(Fig. 6f).
To examine how this biochemical gain-of-function mutation manifests as a recessive Ptcd 
allele, we analyzed T cells from Ptcd/+ and Ptcd/− mice. As expected, the Coro1A 
distribution in Ptcd/− T cells (Fig. 6g) was similar to Ptcd/Ptcd T cells (Fig. 6a). In Ptcd/+ T 
cells, Coro1A was present both at and mislocalized away from the leading edge (Fig. 6g). 
These results suggest that in Ptcd/+ heterozygote cells, Coro1AWT can access the leading 
edge to regulate actin dynamics. In summary, the biochemical studies indicate that the 
highly conserved Glu26 residue in Coro1A is important for regulation of Arp2/3.
Coronin-1A is deficient in a T− B+NK+ SCID patient
With Coro1A point mutations causing severe T lymphopenia in both Ptcd and Koy, we 
asked whether mutations in CORO1A could also be responsible for human primary T cell 
immunodeficiency cases with undefined etiologies. Thus, we sequenced CORO1A in DNA 
from sixteen SCID patients lacking mutations in previously recognized T−B+NK+ SCID 
genes. While we failed to detect any CORO1A mutations in fifteen samples, we did identify 
a single patient with a two nucleotide deletion in exon 3, c.248 249delCT (Fig. 7a), resulting 
in a frameshift and premature stop codon (p.Pro83ArgfsX10) within the CORO1A beta-
propeller domain. Consistent with a destabilizing truncation, immunoblot analysis of Epstein 
Barr virus-immortalized B lymphoid cell lines derived from the patient’s peripheral blood 
showed an absence of CORO1A protein (Fig. 7b). When this patient was 13 mo. old, she 
was hospitalized with a severe post-vaccination varicella infection. She was later diagnosed 
as an atypical T−B+NK+ SCID patient and treated by allogeneic bone marrow 
transplantation; her father, but not mother or sister, was heterozygous for the CORO1A 2bp 
deletion (Fig. 7a).
To test for CORO1A gene copy loss in the patient, we performed genomic QPCR with non-
overlapping primers spanning CORO1A introns 1 through exon 11 and observed ~2-fold 
deficiency in product compared to a healthy control (Fig. 7c). In contrast, S1PR1 (human 
S1P1 gene) on chromosome 1 and CORO7 (CORONIN-7) located telomeric to CORO1A on 
chromosome 16p, did not differ from the QPCR signal in control cells. Taken together with 
recent reports of copy number variation in chromosome 16p11.2, where CORO1A is located 
16–18, these data suggest that our patient, who inherited a 2bp paternal deletion in one allele 
of CORO1A, has a deletion of her other CORO1A allele.
Shiow et al. Page 6
Nat Immunol. Author manuscript; available in PMC 2009 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
DISCUSSION
Through a forward genetics approach, we have identified a unique Coro1a allele that allows 
us to establish a requirement for this actin-regulatory protein in T cell egress from thymus 
and lymph nodes. Two-photon microscopy reveals that Coro1A is needed for normal T cell 
motility within the lymph node and in vitro motility studies indicate a role in cell shape 
regulation. Moreover, this mutation reveals a site on Coro1A critical for Arp2/3 regulation 
and for the control of Coro1A distribution in the cell. Finally, we demonstrate that human 
CORO1A-deficiency can be associated with a peripheral T cell-deficiency of such severity 
to cause T−B+NK+SCID.
The identification of a critical role for Coro1A in thymic and lymph node egress provides 
evidence that migration from these tissues depends on proper regulation of Arp2/3-mediated 
actin branching, most likely in response to S1P. mDia1, a member of the formin family of 
actin nucleating proteins that promote formation of unbranched actin filaments is also 
needed for thymic egress 19. Thus, both the formation of correctly branched as well as 
unbranched actin networks appears to be required for exit from this organ. The role of 
mDia1 in lymph node egress has not been assessed. The small G-proteins Rac and Cdc42 
induce activation of the Wiskott-Aldrich syndrome protein (WASP)-Arp2/3 system and 
consistent with the studies here, the Rac activator DOCK2 is needed for lymph node egress 
20. Although the role of DOCK2 in thymic egress has not been determined, given the need 
for Coro1A we anticipate DOCK2 will also be involved. Lymphocyte protrusions initiate 
diapedesis 21 and our findings suggest that Coro1A-dependent control of actin may play a 
critical role in the formation of protrusions during T cell egress.
The requirement for Arp2/3-mediated actin branching for T cell migration responses to 
chemoattractants has been supported by findings in DOCK2, WASP and WASP-interacting 
protein deficient cells 20,22,23 as well as Coro1A-deficient cells 6,7. Our results with Ptcd 
T cells add to these findings and suggest an important role for Coro1A-mediated Arp2/3 
regulation in the control of T cell shape. A recent study argued that F-actin dynamics were 
unaltered in Coro1A-deficient T cells, although it did not examine cell migration in response 
to chemoattractants 8. The basis for these discrepant findings is unclear but it seems possible 
that the very poor survival of Coro1A-deficient naive T cells and their consequent depletion 
from T cell preparations relative to effector and/or memory T cells confounded some of the 
comparisons. In the present study we have been cautious to exclude both dead cells and 
effector or memory cells from our naive T cell analysis. Although Ptcd T cell migration was 
strongly reduced in vitro and within the lymph node, it was not absent and this might explain 
the continued ability of the Ptcd mouse thymus to organize into cortex and medulla3. The 
lack of marked defects in Ptcd and Coro1A-deficient B cells seems likely to be due to 
redundancy with other coronin family members and adds to other data establishing 
differences in requirements for B and T cell motility 19,24,25. Whether mutations in 
Coro1A or other actin regulatory genes cause defects in common lymphoid progenitors 
remains to be seen. While bone marrow chimera reconstitution efficiencies were similar 
between Ptcd and control donors, our studies have not formally addressed whether entry of 
early thymic precursors is impaired. It will be valuable in future studies to perform 
competition assays with mixed bone marrow chimeras to evaluate the proportion of Ptcd 
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derived cells in bone marrow and thymus. Leukocyte migration within lymphoid tissue has 
been described as phases of force-generating actin protrusions followed by myosin-
dependent contractions 26 that aid the squeezing of the cell nucleus through three-
dimensional matrices. In this regard it is notable that Ptcd T cells not only display large and 
dysmorphic protrusions but also fail to elongate their nuclei. Thus, Coro1A remodeling of 
the actin cytoskeleton may contribute to both protrusion and contraction during T cell 
migration through lymphoid tissues.
The mechanism by which coronins inhibit Arp2/3-mediated actin branching is complex and 
incompletely understood. Although several studies have shown coronins are able to directly 
bind Arp2/3 and possibly inhibit function prior to F-actin binding 27,28, recent work on 
Coro1B in fibroblasts suggests that it acts by displacing Arp2/3 from actin branch points29. 
We demonstrate the involvement of a Coro1A surface proximal to the predicted F-actin 
binding region13 as being involved in Arp2/3 regulation. Our findings highlight the 
importance of characterizing the highly conserved Glu26 containing surface of the type I 
coronin subfamily in future structure-function studies focusing on how an oligomeric 
coronin complex dislodges Arp2/3 from F-actin. The failure of Coro1AE26K to localize 
normally to the leading edge of migrating cells identifies what may be another level of 
coronin regulation. Further studies will be needed to determine whether interactions with the 
cofilin phosphatase, slingshot5, or other still unknown coronin binding partners are altered 
by the mutation.
Coro1A-deficiency causes a severe defect in T cell survival but the basis for this effect is not 
yet resolved. While the Ptcd is an important allelic comparison that disconnects the survival 
and Ca2+ flux defects, the elevated phalloidin staining in Ptcd/− mature thymocytes also 
fails to support a simple correlation between survival and F-actin accumulation. The 
possibility that Coro1A directly impacts cell survival independent of effects on F-actin 
remains, and analysis of additional Coro1A mutations may yield new allelic insights. The 
continued ability of Ptcd thymocytes to maintain near normal total cellular F-actin despite 
the mislocalization of the Coro1A protein might be explained by ongoing association of low 
but sufficient amounts of Coro1AE26K to achieve partial leading edge Arp2/3 regulation, or 
might reflect a corresponding increase in actin-debranching and depolymerization in the cell 
body. Alternatively, the in vitro assay for examining Arp2/3 and Coro1A colocalization may 
not accurately reflect how these proteins distribute in vivo in migrating thymocytes. The 
similar partial deficiencies in TCR-induced Ca2+ flux in Coro1AE26K and Coro1a−/− T cells 
are in agreement with emerging evidence that an intact actin cytoskeleton is important for 
Ca2+ flux 30. But our finding that CD3-CD4 co-crosslinking led to equivalent Ca2+ flux in 
wild-type, Coro1AE26K and Coro1a−/− thymocytes, along with a recent report6 that found 
normal proliferation of Coro1a−/− T cells stimulated by antigen-presenting cells, suggest 
that Coro1A may have a limited role in TCR signaling during cognate antigen encounters. 
We anticipate that single cell analysis of calcium store release and CRAC channel activity in 
Ptcd and Coro1A-deficient mature thymocytes and T cells, along with similar studies of T 
cells with other actin regulatory protein defects, will add to future understanding of how the 
actin cytoskeleton contributes to calcium signaling.
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An important challenge with studies in mouse models is translation of the findings to 
humans. The identification of a patient with a peripheral T cell deficiency who lacks 
expression of Coro1A strongly suggests that Coro1A has similar functions in humans as in 
mice. While the human X-linked Wiskott Aldrich syndrome has long associated actin 
biology with haematopoietic cell dysfunction, the CORO1A deficient patient allows us to 
link regulation of the actin cytoskeleton with SCID 31. T−B+NK+ SCID has previously been 
defined by mutations impairing TCR or IL-7R signaling 32. Other forms of SCID involve 
defects in purine metabolism, DNA recombination, or cytokine signaling 33. Mutations in 
these pathways result in apoptosis through purine toxicity, deficient cytokine signaling, or 
failure to rearrange a signaling competent antigen receptor. With CORO1A deficiency, we 
can also include apoptosis through actin dysregulation as a cause of SCID. A recent report 
classifying a Coro1a-null allele as an autoimmune-suppressing locus in mice 7 is consistent 
with Coro1A defects causing immunodeficiency. We predict that mutations in other 
hematopoeitic-specific actin-associated molecules will be found to cause SCID. Because the 
pericentromeric segment of human chromosome 16 containing CORO1A is prone to copy 
number variation 16–18, we also anticipate that additional cases of patients with reduced T 
cell function will involve CORO1A mutations.
METHODS
Mice, ENU-mutagenesis and bone marrow chimeras
C57BL/6 (B6) and B6-CD45.1 mice were obtained from Jackson Laboratories, National 
Cancer Institute, or a colony maintained at the University of California, San Francisco. 
UBC-GFP mice were purchased from Jackson Laboratories. Cataract Shionogi (CTS/Shi) 
mice were purchased from TGC (Tokyo, Japan). The Ptcd locus was backcrossed 6–10 
generations onto B6 using SNP markers as described below. Coro1a−/− mice, which were 
backcrossed 10 generations with B6, were generated as described 6. Koyaanisqatsi (Koy) 
mice were identified in an ENU-mutagenesis screen performed as described 34 using B6 
mice in a colony maintained at the Australian National University. Briefly, male B6 mice 
were treated with three doses, 1 wk apart, of 100 mg/kg N-ethyl-N-nitrosourea (Sigma) in 
10% ethanol, citrate buffer (pH 5.0) to produce G0 mice. Following an 8 wk refractory 
period, these G0 males were mated with B6 females to generate G1 offspring. Two 
unrelated G1 mice were crossed producing G2 mice, which, were then intercrossed to yield 
G3 mice. Screening of these G3 mice by flow cytometry identified the Koy phenotype. All 
mice were housed in specific pathogen-free conditions; and all protocols were approved by 
the Institutional Animal Care and Use Committee of the University of California, San 
Francisco, or the Australian National University AEEC. Bone marrow chimeras were 
generated with 2–3 × 106 bone marrow cells from donor mice intravenously transplanted 
into lethally irradiated congenic hosts. Chimeras were given prophylactic antibiotic water 
and analyzed 8–12 weeks after transplantation.
Flow cytometry, intracellular stains and calcium flux measurements
S1P1 polyclonal antibody was previously described 35. Phalloidin-FITC was from Sigma. 
Indo-1 was from Invitrogen. Intracellular staining and Annexin-V staining kits were from 
BD Bioscience. JC-1 mitochondrial membrane potential staining kit was from Cayman Inc. 
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All other antibodies used for flow cytometry were obtained from BD Biosciences, 
Invitrogen, eBiosciences, or BioLegend. Calcium flux assays were adapted from previously 
described methods for thymocytes 14. Briefly, cells were loaded at 30 °C for 30 min with 
Indo-1 in the presence of biotinylated anti-CD3 (clone 2C11, BD), anti-CD8 FITC (clone 
53-6.7, BD), and anti-CD4 Alexa647 (clone RM4-5, BD). Thymocytes were additionally 
stained with anti-CD62L PE (clone Mel14, BD) and splenocytes with anti-CD44 PE (clone 
IM7, BD). Cells were washed and kept on ice until analysis. For anti-CD4 co-crosslinking, 
cells were additionally pre-treated for 5 min with biotinylated anti-CD4 (clone RM4-4, BD). 
Cells were mixed with pre-warmed media containing propidium iodide for exclusion of dead 
cells and warmed to 37 °C. Baseline calcium levels (ratio of UV-short to long) were 
assessed for 30 sec prior to streptavidin (50 ug/mL; Pierce) crosslinking. All flow cytometry 
was performed on BD FACalibur or BD LSRII.
Purification of recombinant protein
Coronin recombinant protein was expressed and purified with a mammalian expression 
system as described previously for Coronin 1B 15. Purified protein was quantified from 
absorbance at 280 nm and the predicted extinction coefficients of 62910 M−1cm−1 (Coronin 
1A) and 65890 M−1cm−1 (Coronin 1B).
Immunoprecipitation
Cells were washed twice with phosphate-buffered saline and lysed with a KCl buffer (20 
mM HEPES, pH 7.0, 100 mM KCl, 0.5% Nonidet P-40, 1 mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride, 10 μg/ml 1,10-phenanthroline, 10 μg/ml aprotinin, 10 μg/ml 
leupeptin, 10 mM sodium fluoride, and 2 mM sodium orthovanadate). Lysates were cleared 
at 13,000 × g for 5 min and incubated with 0.5 μg of primary antibody for 16 h at 4 °C, 
followed by the addition of 20 μl of 50% slurry of ImmunoPure-immobilized protein A/G 
beads (Pierce) and further incubation at 4 °C for an additional hour. The immune complexes 
were collected, washed with the KCl buffer three times, separated by SDS-PAGE, and 
transferred to a polyvinylidene difluoridemembrane (Bio-Rad) for immunoblotting.
Actin assembly assay
VCA-induced Arp2/3 nucleation reactions were performed as previously 15: recombinant 
Coronin and Arp2/3 (20 nM) were mixed in MKEI-50 Buffer and incubated at room 
temperature for 5 min; reactions were initiated by the simultaneous addition of 1.5 μM actin 
(5% pyrene labeled, primed with 1 mM EGTA and 0.1 mM MgCl2 for 90 s) and 1 nM GST-
VCA. The delay between mixing reactants and recording fluorescence was 15 seconds. 
Fluorescence was converted to the molar concentration of F-actin from the fluorescence of 
completely polymerized (24 hr post reaction) and unpolymerized actin, assuming a critical 
concentration of 0.1 μM.
Immunoblot
Lysates from mouse thymocytes and human EBV-immortalized cell lines were prepared in 
RIPA buffer (1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50mM Tris-pH8.0, 
150mM NaCl, 0.02 NaN3), resolved (NuPage, Invitrogen) and transferred (XCell, 
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Invitrogen) to Immobilon-FL (Millipore), blocked and probed with LICOR buffer, and 
analyzed on an Odyssey Infrared Imager (LICOR). Anti-Coro1A was from Upstate; anti-
actin from Sigma, and secondary IREDye antibodies were from Rockland.
Transwell migration
Transwell migration assays (5 micron; Corning) were performed with thymocytes or 
splenocytes collected in migration media (RPMI (Cellgro) supplemented with 10 mM 
HEPES (Cellgro), 100 U/mL penicillin-streptomycin (Cellgro), and 0.5% Fatty Acid Free 
BSA (Calbiochem)). For S1P migration, thymocytes were assayed immediately after 
isolation. For chemokine migration, thymocytes or RBC-lysed splenocytes were resensitized 
in migration media for 30 min at 37 °C. S1P (Sigma), human SDF-1a (Peprotech) and 
mouse CCL21 and CXCL13 (R&D Systems) were used at the concentrations indicated.
Adoptive cell transfers and treatments
Thymocytes were labeled with CFSE or CellTracker Orange CMTMR (Molecular Probes) 
as described 36. For adoptive transfer, mice were injected intravenously with ~1–3 × 107 
cells in ~0.3 mL of media. For homing assays, mice were analyzed 1 h post-transfer. For 
peripheral egress assays, mice were analyzed 24 h post-transfer or treated intravenously with 
entry blocking antibodies for 20 h and analyzed after 44 h. Antibodies used for in vivo entry 
blockade were previously described 37.
Two-photon microscopy
Thymocytes from donor mice were isolated and labeled with CellTracker Orange CMTMR 
(Invitrogen-Molecular Probes) as described 38 and intravenously injected with thymocytes 
from UBC-GFP mice into B6 recipient mice. After 12–24 h, inguinal lymph nodes were 
isolated for two-photon microscopy, and axillary and brachial lymph nodes were isolated for 
flow cytometry. Flow cytometric analysis confirmed that >90% of CMTMR-positive cells in 
lymph nodes were mature single-positive thymocytes (CD4+CD8−CD69loCD62Lhi or 
CD4−CD8+ CD69loCD62Lhi). Explants were prepared as described 39. Inguinal lymph 
nodes were perfused with RPMI (Cellgro) at 36–37 °C, aerated with 95% O2/5% CO2, and 
were imaged from the cortical side of the lymph node through the capsule. A ‘custom’ two-
photon microscope system was used for imaging, with the 5-W MaiTai TiSapphire laser 
(Spectra-Physics) tuned at an 890 nm excitation wavelength. Images were captured with 
Video Savant software (IO Industries). For time-lapsed imaging, 30–36 planes spaced 3 um 
apart were collected every 20 s. Each xy plane spanned 240 um × 288 um at a resolution 0.6 
um per pixel. Data were further processed with MetaMorph software (Molecular Devices). 
Imaris software (Bitplane AG) was used for three-dimensional volume rendering and cell 
tracking. Matlab software was further used to calculate cell velocities, turning angles, and 
displacement. Statistical significance was evaluated with a paired two-tailed Student’s t-test.
Genetic mapping, SNP analysis, human samples, and sequencing
CTS/Shi mice were crossed with B6 to generate an F1 generation. The Ptcd locus was 
mapped with mutant F2 progeny from F1 intercrosses, F1 backcrossed to nonparental CTS, 
or mutant F2 crossed with nonparental F1. Mice were phenotyped by flow cytometric 
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analysis of thymocyte subset frequencies. Genomic DNA was isolated from tails (Wizard 
Genomic Kit, Promega) and SNP reactions were performed with Amplifluor HT-kit 
(Chemicon, Millipore) on an ABI7300 (Applied Biosystems) according to manufacturer’s 
instructions. Mapping SNPs were selected based on polymorphisms between B6 and BUB/J, 
a strain closely related to CTS/Shi. SNP primers were designed on the AssayArchitect 
website. Patients with SCID and their parents, if available, were enrolled with informed 
content in IRB-approved protocols to determine genotype and genotype/phenotype 
correlations. Blood samples were immortalized with Epstein-Barr Virus (EBV) to create B 
cell lines. Human genomic DNA was isolated from buccal swabs or EBV-immortalized lines 
with a Puregene kit (Gentra Systems). Genomic QPCR was performed on an ABI7300. 
Human and mouse Coro1a exons and surrounding splice regions were amplified by PCR 
from genomic DNA, resequenced, and analyzed on 4Peaks relative to reference human 
genomic and cDNA sequences NM_007074 and NM_007074.2, respectively. Primers are 
summarized in Supplementary Table 1 online.
Brightfield and immunofluorescenct microscopy
For fixed immunofluorescent imaging, 1–2 × 106 lymphocytes from peripheral and 
mesenteric lymph nodes were seeded on chambered coverslips (Lab-tek, Nunc) precoated 
with 10 ug/mL recombinant mouse ICAM1-Fc (R&D Systems), and allowed to settle and 
migrate in the presence of 1 ug/mL CCL21 (R&D Systems) for 1 h at 37 °C in RPMI 
(Cellgro) supplemented with 1% Fetal Calf Serum (Invitrogen), 10mM HEPES (Cellgro), 
and 100 U/mL penicillin-streptomycin. Cells were then fixed with 4% (wt/vol) 
paraformaldehyde (Sigma) and permeabilized with 0.5% Triton-X100 (Sigma) in PBS. 
Coverslips were then stained with a combination of the following: anti-Coronin-1A (rabbit 
polyclonal, Millipore/Upstate) or anti-p34Arc (rabbit polyclonal, Millipore/Upstate), FITC-
conjugated phalloidin (Sigma), Alexa647-conjugated anti-CD4 (clone RM4-5, BD), 
Alexa647-conjugated anti-CD8 (clone 53-6.7, BD), biotinylated goat anti-rabbit (BD), 
streptavidin-Cy3 (Jackson Immuno), or DAPI (Molecular Probes). Z-stacks were captured 
on an Axiovert Z1 (Zeiss) and deconvoluted with Axiovision Software (Zeiss). For real-time 
imaging, 5 × 105 lymphocytes from peripheral and mesenteric lymph nodes were stained 
with PE-conjugated anti-CD19 (clone 1D3, BD) and Alexa647-conjugated anti-CD4 and 
anti-CD8 and seeded on ICAM-coated chambered coverslips with CCL21 as described 
above with the addition of 0.1% NuSieve GTG Low Melt Agarose (FMC BioProducts) and 
DAPI. Cells were maintained at 37 °C and 5% CO2 during 3–4 h of imaging in an 
environmentally-controlled stage on an Axiovert Z1. Each 5 min movie was generated with 
10 s time-lapse intervals containing 6 brightfield 0.5 micron z-stacks. Following time-lapse, 
a fluorescence image was captured to identify live T cells. Movies and images were 
processed with Axiovision (Zeiss) and exported for annotation and splicing with 
AfterEffects (Adobe).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Peripheral T cell deficiency (Ptcd) is an intrinsic T cell migration. (a, b)
Thymocyte and peripheral blood lymphocyte subsets from B6 Ptcd (white) and control mice 
(black) (a), or wild-type mice reconstituted with Ptcd (white) or control (black) bone 
marrow (b). Columns represent means and circles represent individual mice. (c) Flow 
cytometric analysis of S1P1 on mature CD4SP thymocytes from Ptcd (solid) and control 
(dotted) mice; isotype control in filled histogram. Representative of three experiments. (d–f) 
Transwell migration of Ptcd (white) or control (black) mature CD4SP thymocytes to S1P in 
(d), thymocytes to indicated chemokines in (e), or splenic naive CD4+ T cell or CD19+ B 
cells to indicated chemokines in (f), are shown as percentage of input that migrated. 
Columns represent means and circles represent individual mice pooled from three or four 
experiments. ** P < 0.05
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Figure 2. Ptcd T cells are defective in lymph node trafficking
(a,b) Homing to lymph nodes 1 h (a) and egress into lymph 24 h (b) following adoptive co-
transfer of Ptcd (Ptcd/Ptcd) and control (Ptcd/+) thymocytes represented graphically as the 
ratio of Ptcd to control cells normalized to the injection Ptcd: control ratio. To achieve ~1:1 
lymph node ratio at 24 h, initial injections were performed at a 3:1 ratio. Columns represent 
means and circles represent individual mice pooled from three experiments. (c) Fraction of 
Ptcd or control cells retained in the mesenteric (mLN) or peripheral (pLN) lymph nodes 20 h 
following treatment with integrin neutralizing antibody. Columns represent means and 
circles represent average values from independent experiments conducted with four mice 
each. (d–f) Time-lapse two-photon microscopy of explanted lymph nodes containing Ptcd 
and heterozygote control cells. Data representative of three independent experiments with at 
least 40 tracks analyzed in each. Mean velocities (d) and turning angles (e) of Ptcd cells 
(white) or control cells (black). Columns represent means and circles represent individual 
experiments. (f) Average of displacement squared <R2> over time of Ptcd (open diamond) 
or control cells (black circle). Symbols represent means and bars represent standard 
deviation. Het, control cells (Ptcd/+). ** P < value<0.05
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Figure 3. Coro1A is mutated at the Ptcd locus. (a)
Representative flow cytometric analysis of Ptcd mapping cross progeny used to phenotype 
affected or unaffected mice. Phenotype scored on single-positive frequencies, fraction of 
CD62Lhi CD69lo CD4SP, and expression level of CD62L in CD8SP. (b) Ptcd critical 
interval defined by SNP markers polymorphic between B6 (black) and CTS (white) within 
indicated recombinant mice. (c) Schematic of open reading frames within the 950kb Ptcd 
critical interval (adapted from Ensembl). (d) Dideoxy sequence tracings of DNA from Ptcd 
and heterozygous mice revealing a 76G->A mutation causing a protein E26K substitution. 
DNA from the related NOD mouse strain was used as an additional control. (e) Schematic of 
Coro1A structure with Ptcd point mutation indicated. (f) Immunoblot analysis of total 
thymocytes from Ptcd and control mice for Coro1A and actin. Samples loaded in threefold 
dilutions. NC, negative control (Coro1a−/−). Respresentative of three experiments.
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Figure 4. ENU-mutant Koyaanisquatsi is a Coro1A hypomorph
(a) Flow cytometric analysis from peripheral blood of Koy and littermate control mice 
demonstrated deficiency of TCRαβ+ T lymphocytes (left). Lymphocytes subsets in 
peripheral blood of Koy (white) and control (black) mice (right). Columns represent means 
and circles represent individual mice. (b) Flow cytometric analysis of thymocyte subsets 
from Koy (white) and control (black). Columns represent means and circles represent 
individual mice. (c) Transwell migration of Koy (white) or control (black) double positive 
thymocytes, mature CD4SP thymocytes or splenic naive CD4+ T cell to indicated 
chemokines are shown as percentage of input that migrated. Columns represent means and 
circles represent individual mice pooled from three experiments. (d) Flow cytometric 
analysis of phalloidin staining in mature CD4SP thymocytes from Koy (blue lines) and 
control mice (red lines). Each line is an individual mouse. Representative of at least three 
independent experiments. (e) Dideoxy sequence tracings from genomic tail DNA of Koy and 
control mice. (f) Immunoblot analysis from Koy and control mice as described in Fig. 3f. ** 
P < 0.05
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Figure 5. Allelic comparison of survival with F-actin accumulation and Ca2+ flux. (a,b)
Apoptosis assessment by loss of mitochondrial membrane potential (a) or annexin-V 
staining (b) of mature CD4SP thymocytes (top) or naïve CD4+ T cells (bottom) from wild-
type, Coro1a ‘knockout’ and Ptcd mice following 4h incubation on ice (black) or at 37 °C 
(white). Pooled from three independent experiments. ** P < 0.05 (c) Flow cytometric 
analysis of phalloidin binding in mature CD4SP thymocytes (top) or naïve CD4+ T cells 
(bottom) from wild-type, Coro1a knockout and Ptcd mice. Representative of at least three 
experiments. (d) Measurement of intracellular Ca2+ in mature CD4SP thymocytes (top) or 
naïve CD4+ T cells (bottom) from wild-type, Coro1a knockout and Ptcd mice; prebound 
antibodies to CD3 or to CD3 and CD4 were crosslinked by addition of streptavidin at the 
time indicated. Dead and dying cells were excluded with propidium iodide staining. 
Representative of three experiments.
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Figure 6. E26K mutation alters Coro1A cellular distribution and regulation of Arp2/3. (a–c)
Immunofluorescent microscopy of T cells migrating on ICAM-coated coverslips in 1 ug/mL 
CCL21. Cells were stained for F-actin and (a) Coro1A or (b) Arp2/3 subunit p34 (b); and 
still images from brightfield time-lapse microscopy (c). White bar indicates 5 microns. Time 
stamp reflects min:sec. Data are representative of three experiments. (d) Co-sedimentation 
assay of indicated purified coronins and F-actin. S, supernatent. P, pellet. (e) Lysates from 
HEK293FT cells expressing indicated constructs were immunoprecipitated with anti-p34 
and blotted with indicated antibodies. *GFP degradation bands. (f) Arp2/3-induced actin 
polymerization assay with indicated concentrations of purified coronins. WT, wild-type 
coronin. E26K, mutant coronin. AVA, standard mixture of actin, VCA and Arp2/3 complex 
(g) T cells from Ptcd/+ and Ptcd/− stained as in a.
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Figure 7. CORONIN-1A is deficient in a T−B+NK+ SCID patient. (a)
Family pedigree and dideoxy sequence tracings from the patient and family members, with a 
red arrow (and empty red rectangle) indicating the location of c.248delCT in the patient that 
is heterozygous in the father and leads to a premature truncation after 10 missense codons. 
The father’s sequence tracing is annotated to show both the mutated (top) and normal 
(bottom) copies. The CT nucleotides that are missing in the patient and in the father’s 
mutated allele are boxed in the father’s unmutated allele and in the sequence tracings 
obtained for the mother and sibling. (b) Immunoblot analysis for CORO1A and actin from 
EBV-transformed B cell lines derived from indicated subjects. Representative of three 
experiments. (c) Genomic QPCR signals from indicated primer sets of S1PR1, CORO7 and 
CORO1A from buccal swab DNA of the SCID patient and normal control. Column 
represents mean and circles represent separate PCR reactions.
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